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1. Introduction
In the last few years the clinical management of rectal cancer has become very complex. A
wide spectrum of therapeutic options is available. Magnetic Resonance Imaging (MRI) could
play a pivotal rule in the prognostic and therapeutic assessment of rectal cancer (Chen et al.,
2005).
As known, MRI can provide information about the stage of the disease according to
TNM classification focussing on the depth of mesorectal invasion and on lymph node
involvement inside and outside the mesorectum (Beets-Tan & Beets, 2004; Gunderson et al.,
2004). Due to its intrinsic multiparametricity and multiplanarity MRI is considered the
‘gold standard’ particularly in differentiating between intramural and extramural disease,
and in the management of Locally Advanced Rectal Cancer (LARC) (Beets-Tan & Beets, 2004;
Petrillo et al., 2006).
The common use of total mesorectal excision (TME) and the shift from a postoperative to
a preoperative chemo-radiotherapy (pre-CRT) approach have substantially reduced the risk
of local recurrences, increasing curative resection and the rate of anal sphincter preservation
and improving local control and overall survival rates (Avallone et al., 2006; 2011; Delrio et al.,
2005; 2003).
Although morphological tumour assessment performed by MRI has been repeatedly shown
to be the most accurate modality in evaluating the presence of a positive circumferential
resection margin (CRM), MRI is considered not to be conclusive in pre-CRT tumor response
evaluation since histopathological downstage is not always associated with tumour effective
reduction (Petrillo et al., 2007). The main difficulty regarding post-chemoradiation MRI
includes discrimination of active tumour and post-treatment fibrosis, particularly when
differentiating stage T2 and stage T3 carcinomas, according to different recurrence and overall
survival rates between Low Risk (T1/T2N0) and Intermediate Risk (T3/N0) as reported by
Gunderson et al. (2002; 2004).
Previous considerations support a Dynamic Contrast Enhanced-Magnetic Resonance Imaging
(DCE-MRI) approach that could gain a renewed role to MRI adding functional data to
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the morphological examination. DCE-MRI has been reported by many authors as a tool
potentially able to permit an evaluation of pre-CRT effectiveness basing on the strict
relationship between tumor growth and angiogenesis (Ceelen et al., 2006; de Lussanet et al.,
2005; Kremser et al., 2007).
DCE-MRI is gaining a large consensus as a technique for diagnosis, staging and assessment
of therapy response for different types of tumours, due to its capability to detect highly
active angiogenesis. It is well known that angiogenesis is a key factor in the growth and
dissemination of cancer; characterisation of the angiogenic status of the tumour on an
individual patient basis could allow for a more targeted approach to treatment of rectal cancer
(Goh et al., 2007; Kapse & Goh, 2009).
More specifically, in the case of rectal cancer, previous trials have provided the proof of
principle that inhibition of angiogenesis has the potential to enhance the effectiveness of the
treatment for this disease. In vivo imaging techniques capable to assess tumour perfusion
have the potential to improve the management of treatment for patients with rectal cancer
(Chen et al., 2005; de Vries et al., 2000; 2001; 2003; Kremser et al., 2007).
The aim of this chapter is to review the main issues concerning the assessment of the
angiogenic status of rectal cancer by means of DCE-MRI. More specifically, the aim of this
chapter is to present:
• a review of the widespread methodologies used for DCE-MRI data acquisition and
analysis;
• the main findings of scientific literature concerning DCE-MRI evaluation of rectal cancer.
2. DCE-MRI basis
Cancer can develop in any tissue of the body that contains cells capable of division. The
earliest detectable malignant lesions, referred to as cancer in situ, are often a few millimeters
or less in diameter and at an early stage are commonly avascular. In avascular tumours
cellular nutrition depends on diffusion of nutrients and waste materials and places a severe
limitation on the size that such a tumour can achieve. The maximum diameter of an avascular
solid tumour is approximately 150 − 200µm, and is governed effectively by the maximum
diffusion distance of oxygen. Conversion of a dormant tumour in situ to a more rapidly
growing invasive neoplasm, may take several years and is associated with vascularization of
the tumour. The development of neo-vascularization within a tumour results from a process
known as angiogenesis.
There are positive and negative regulators of angiogenesis. Release of a promoter substance
stimulates the endothelial cells of the existing vasculature close to the neoplasia to initiate
the formation of solid endothelial sprouts that grow toward the solid tumour (Knopp et al.,
1999). Vascular endothelial growth factor (VEGF) also known as vascular permeability factor
(VPF), induces angiogenesis and strongly increases microvascular permeability to plasma
proteins. As vascular growth factors are released, proteases are also induced to degrade
perivascular tissue, allowing the endothelial cells to proliferate and form primitive, immature,
and, therefore, leaky vessels (Dor et al., 2001; Guetz et al., 2006). Figure 1 summarizes the
main phases of tumor vasculature development.
Therefore, the morphology of the neo-vascular network in tumours can differ significantly
from that seen in normal tissue. Tumour vasculature is often highly heterogeneous, and the
capillaries are extremely coarse, irregularly constricted or dilated and distorted.
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Fig. 1. A summary of the main phases of tumor vasculature development (angiogenesis) and
the effects that are measurable by means of DCE-MRI.
Fig. 2. DCE-MRI in rectal cancer: a series of T1-weighted images before and after CA
injection; the time-intensity curve of the selected region of interest (ROI) is also shown.
Angiogenic inhibitors can reduce both the number of vessels (particularly nonfunctional
vessels) and their permeability. Some therapies, such as anti-vascular endothelial growth
factor antibody (antiVEGF Ab), are specifically directed against a growth factor (VEGF) and
are thought to regulate vascular maturation and permeability (Lichtenbeld et al., 1999).
While avascular tumours are not detectable by MRI (Choyke et al., 2003), DCE-MRI can
help to characterise vascularized cancers (Leach et al., 2005). After intravenous injection,
the contrast agent (CA) pass through the tumor vasculature and immediately leaks through
the vessels walls accumulating in the extravascular extracellular space (EES) because of the
concentration gradient (wash-in phase, see fig. 2). Hereafter, CA concentration within
plasma will return lower than EES and backflow will occur (wash-out phase). Using specific
T1-weighted pulse sequences the accumulation of CA causes an increase of signal intensity
(enhancement) on images (fig. 2). Malignant tumors generally show faster and higher levels
of enhancement than is seen in normal tissue. DCE-MRI is currently widely used in the study
of tumour angiogenesis and in the development and trial of anti angiogenic drugs.
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3. DCE-MRI data acquisition
Several issues of data acquisition should be taken into account when developing protocols
for DCE-MRI, both to facilitate the integration of results from multiple institutions and to
ensure that the data reflect the underlying physiology as accurately as possible (Ashton, 2010;
Evelhoch, 1999; Leach et al., 2005).
In particular, the type of data acquisition affects the data analysis procedure: while
semi-quantitative model-free analysis (see section 4) can be performed without accurate
measurement of CA concentration, a full model-based approach requires accurate CA
quantification.
Key factors affecting DCE-MRI of rectal cancer include: type of contrast agents and the
relationship between CA concentration and signal enhancement; constraints concerning
spatial and temporal resolution; the impact of patient motion.
3.1 Relationship between contrast agent concentration and signal enhancement
It is generally assumed that the relaxation rate (R1 = 1/T1) of soft tissues is linearly related to
the mean tissue CA concentration (CT) via the Bloembergen and Solomon equation:
R1 =
1
T1
=
1
T1,0
+ r1CT = R1,0 + r1CT (1)
where T1,0 and R1,0 are, respectively, the relaxation time and the relaxation rate of the tissue
in absence of CA and the proportionality constant r1 is called ‘relaxivity’.
Main properties concerning the relaxivity include: it depends upon the macromolecular
environment; it is dependent on the type of macromolecule to which the Gd ion is attached; it
decreases with external magnetic field; it increases with temperature; and it is also dependent
on the pH of the solution (Stanisz & Henkelman, 2000).
However, most studies assume that r1 is constant at a given temperature and magnetic field
and that it is independent on the tissue environment. The typical value used for r1, estimated
in pure saline water, is 4.5 L/mmol/s per kg of water (Stanisz & Henkelman, 2000).
In typical DCE-MRI experiments, T1-weighted spoiled gradient-echo sequences are used. In
this case the signal intensity S has the following expression (Sourbron, 2010):
S = ρ · g ·
sin α · (1− exp(−TR/T1))
1− cos α · exp(−TR/T1)
· exp(−TE/T
∗
2 ) (2)
where ρ is the proton density, g is a constant determined by system receiver and image
reconstruction settings, α is the flip angle, TR is the repetition time, TE is the echo time, T
∗
2
is the transverse relaxation time taking into account field inhomogeneity .
If it is assumed that Gd ions have no effect on ρ and that the TE is so short to neglect the
influence of T2 (or, more importantly, changes in T
∗
2 during the series), then the Gd ions can
influence the signal intensity only by means of their effect on T1 (decrease of T1). Under these
assumptions, and as α approaches 90◦ and TR ≪ T1 the relationship between signal intensity
and 1/T1 becomes approximately linear:
S ≈ ρ · g ·
TR
T1
(3)
this relationship remains approximately valid across a range of values for TR/T1 and α.
Therefore, an estimate of CA concentration can be obtained using eq. (1) and eq. (3):
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[Gd] =
1
r1
(
1
T1
−
1
T1,0
)
≈
S− S0
r1 · ρ · g · TR
(4)
where S0, S, T1,0 and T1 are the signal intensities and spin-lattice relaxation times before
and after administration of contrast agent respectively. The difference S − S0 is called signal
enhancement.
The difficulty in comparing different studies comes from the nature of g: in fact, the loading
of the coil, the receiver settings at the MR console and image reconstruction parameters can
be different among several studies.
Therefore, it could be more advantageous to normalise with respect to the pre-contrast signal
intensity:
[Gd] ≈
S− S0
S0
1
r1 · T1,0
. (5)
The quantity (S− S0)/S0 is called relative signal enhancement. Consequently, the concentration
of CA is related to both r1 and T1,0 of tissue.
As observed before, the relaxivity r1 can be considered fixed for soft tissues. As far as the
longitudinal relaxation time prior to contrast injection (T1,0) it can be easily measured before
CA administration using opportune pulse sequences (Collins & Padhani, 2004).
One common method for T1,0 estimation is to use several gradient-echo (GRE) images with
variable flip angles. In fact, rearranging eq. (2) that equation yields (Parker et al., 1997):
Y(α) = X(α) · exp(−TR/T1,0)− ρg(1− exp(−TR/T1,0)) exp(−TE/T
∗
2 ) (6)
where Y(α) = Sα/ sin α and X(α) = Sα/ tan α. Hence a plot of Y(α) against X(α) for several
(typically three or more) flip angles will result in a straight line and T1,0 can be calculated from
the slope (via standard linear regression).
3.2 Spatial and temporal resolution
The requirements for temporal and spatial resolution for a particular oncologic application
often are in direct conflict. Both the importance for high temporal resolution to
accurately characterize contrast kinetics and the need for high spatial resolution to identify
distinguishing features of lesion morphology have been investigated in several studies
(Cheng, 2008; Dale et al., 2003; Evelhoch, 1999; Henderson et al., 1998).
In general, it can be stated that for an accurate estimation of tracer kinetics parameters, a short
interval between samples must be used, especially for the analysis of the wash-in phase. For
example, Henderson et al. (1998) found that this interval should be approximately less than
16 s in the case of breast DCE-MRI. In the wash-out phase, this requirement could be relaxed
(de Vries et al., 2003; Kremser et al., 2007).
A high temporal resolution can be difficult to obtain because the acquisition of a single volume
could require several seconds as a large part of the whole abdomen is scanned. One approach
to overcome this problem is to choose a single slice containing the tumor, so that the sampling
interval can be maintained below a few seconds (Blomqvist et al., 1998; Ceelen et al., 2006;
de Lussanet et al., 2005). However, this approach is not able to manage with the heterogeneity
of the tumour (Jackson et al., 2007). An hybrid approach could involve a rapid imaging with
low spatial resolution in the wash-in phase while a slow, high-resolution imaging could be
adopted in the wash-out phase (de Vries et al., 2000; 2003).
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Fig. 3. Classification system for semi-quantitative of the TICs. The level of angiogenesis is
supposed to increase with the number of the curve-type: (I) no enhancement; (II) slow
sustained enhancement; (III) rapid initial and sustained late enhancement (persistent); (IV)
rapid initial and stable late enhancement (plateau); (V) rapid initial and decreasing late
enhancement (wash-out). Curves from (I) to (III) are typically associated to normal or benign
tissues; type (IV) can be classified as suspicious and (V) as malignant.
3.3 Patient motion
Since the TIC is sampled over several minutes, patient motion can become a serious obstacle
to an accurate evaluation of kinetic parameters. Motion correction should be applied
before any tracer kinetics analysis is performed (Fei et al., 2002). However, 2D or 3D
registration is difficult because the signal intensity of a pixel can change over time both
because of spatial displacement and CA absorption. Therefore, DCE-MRI specificmethods are
currently being developed for simultaneous iterative registration and tracer kinetics analysis
(Buonaccorsi et al., 2007; Melbourne et al., 2007; Xiaohua et al., 2005).
4. DCE-MRI data analysis
Different methods for DCE-MRI data analysis have been proposed, ranging from simple
semi-quantitative inspection of the time-intensity curves (TICs) to more sophisticated tracer
kinetics modelling (Brix et al., 2010; Sourbron, 2010). The different methods were designed to
capture the biologically relevant components from the dynamic MR signal and to relate them
to the underlying pathophysiological processes taking place in the tissue.
In principle, the derivation of physiological data from DCE-MRI relies on the application of
appropriate tracer kinetics models to describe the distribution of contrast media following
its systemic administration. However, the application of these techniques is still complex
and they cold not be widely available outside specialist centres. In response to this, many
semi-quantitative approaches for the classification of enhancement curve shapes have been
described and are now in relatively common use in clinical settings.
Both semi-quantitative and full-quantitative data analysis can be performed on a region of
interest (ROI) basis or on a pixel-by-pixel basis. We will briefly describe the two approaches.
4.1 Semi-quantitative analysis
Semi-quantitative analysis can help the radiologist in classifying the TIC shape as normal,
benign, malignant (see fig. 3). Classification of TICs according to this scheme can achieve very
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good diagnostic performance in differentiating malignant from benign lesions as described in
the case of breast lesions (Daniel et al., 1998; Kuhl, 2007; Nishiura et al., 2011).
As regards the rectal cancer, many papers explored the possibility to apply a semi-quantitative
approach to lesion classification. Different TIC features have been used by the different
authors, the aim being to extract as much physiological information as possible.
The approaches can be roughly subdivided in two classes. In a first type of approach, the
classification of the TIC is performed by means of several features having, on an intuitive
basis, a link with physiological characteristics (see fig. 4). As an example, Tuncbilek et al.
(2004) used themaximal relative enhancement within the firstminute (MSD1min), the maximal
relative enhancement of the entire study (MSD), the steepest slope (W ISmax). Similarly,
Blomqvist et al. (1998) and Dicle et al. (1999) used MSD and W ISmax.
Another approach is to extract TIC features that are associated to tracer kinetics theory (see
section 4.2). Within this framework de Lussanet et al. (2005); de Vries et al. (2000; 2001; 2003);
Kremser et al. (2007) used, as a first step in quantitative assessment of tumor perfusion, the
steepest slope of the TIC during contrast medium uptake (W ISmax), and, on the base of the
work by Miles (1991) they evaluated the Perfusion Index (PI) as:
PI =
1
σtumor
[
dCtumor/dt|max
Cart|max
]
=
1
σtumor
[
W ISmax
Cp(t)|max
]
(7)
where σtumor is tissue density. Although PI is an approximated parameter, it combines two
important quantities: tissue perfusion and extraction fraction (Brix et al., 2010; Sourbron,
2010).
When calculated on a pixel-by-pixel basis the above parameters can be displayed graphically
as pseudo-colouredmaps superimposed on the correspondingmorphologicalMR images (see
section 4.3, fig. 7).
Figure 4 shows the most important parameters that have been used in several studies. The
definitions of the several quantities are not always in accordance. Therefore we have tried to
use a unifying terminology for semi-quantitative parameters (see tab. 1):
TTK time between the beginning of dynamic acquisition and the maximum enhancement;
TWI time between the onset of enhancement and the maximum enhancement;
TWO time between the maximum enhancement and the end of the acquisition;
MSD the maximum signal level with respect to the baseline;
WIS slope of the wash-in phase (increase in signal intensity between enhancement onset and
maximum enhancement divided by time to peak);
WOS slope of the wash-out phase (decrease in signal intensity between maximum
enhancement and the signal intensity at the end of acquisition divided by time TWO);
WII intercept of the wash-in straight-line with the y-axis;
WOI intercept of the wash-our straight-line with the y-axis;
AUCWI area under gadolinium curve in the was-in phase;
AUCWO are under gadolinium curve in the wash-out phase;
81ynamic Co trast E hanced Ma etic Resonance Imaging in Rectal Cancer
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Fig. 4. Semi-quantitative analysis: illustration of the parameters calculated from the TIC. See
table 1 for definition of terms.
Parameter Definition
TTK Time To Knee
TWI Time of Wash-In
TWO Time of Wash-Out
WII Wash-In Intercept
WOI Wash-Out Intercept
WIS Wash-In slope
WOS Wash-Out slope
MSD Maximum Signal Difference
AUCWI Area Under Wash-In
AUCWO Area Under Wash-Out
Table 1. Semi-quantitative analysis: definition of terms in fig. 4
4.2 Tracer kinetics modelling
The flow of CA within the tissue of interest can be described using compartmental
modelling. Different tracer kinetics modelling approaches have been proposed (Brix et al.,
2010; Sourbron, 2010). Themost widespread one is the two-compartments model (Tofts, 1997).
The advantage of tracer kinetics modelling over semi-quantitative analysis is that it provides
an estimate of physiological parameters directly related to vessels permeability and to blood
flow (and therefore to the angiogenic status of the tissues).
In order to model CA kinetics in terms of physiologicallymeaningful parameters we first need
to define the elements within the tissue and the functional processes that affect the distribution
of the tracer. It is customary to represent the tissue as comprising three or four compartments
(fig. 5). Major compartments are: the vascular plasma space, the extra-cellular extra-vascular
2 Rectal Cancer – A Multidisciplinary Approach to Management
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Fig. 5. Major compartments and functional variables involved in the distribution of the
contrast agent in the tissue.
space (EES), and the intracellular space. A fourth tissue component forms a catch-all for all
the other microscopic tissue components, such as membranes, fibrous tissues, etc.
All clinically utilisedMRI contrast agents, and most experimental agents, do not pass into the
intracellular space of the tissue, due to their size, inertness, and non-lipophilicity, making the
intra-cellular space un-probable using DCE-MRI; for this reason, the intra-cellular and ‘other’
volumes are usually lumped together as a loosely defined ‘intra-cellular’ space.
We will indicate the quantities associated to the EES, plasma and intra-cellular compartments
with the subscripts e, p and i respectively. The quantities associated to the whole tissue will
be marked by a subscript T. The volume occupied by the different compartments may be
expressed either as an absolute value (Ve,Vi,Vp,VT) or as fractions (ve,vi,vp) of VT. They must
satisfy the constraint:
ve + vp + vi = 1. (8)
All the models make some basic assumptions related to concepts in tracer kinetics. The most
important are: the linearity of the tissue (the flux of CA between compartments is proportional
to the difference of CA concentrations in the two compartments); the stationarity of the
tissue (the parameters describing the compartments are constant during data acquisition);
and the tissue is formed of well-mixed compartments (a compartment is said to be well-mixed
when the CA immediately distributes over the whole compartmental volume). Under these
assumptions the rate of wash-in and wash-out of the CA in the EES can be described by a
modified general rate equation (Kety, 1951):
ve
dCe
dt
= Ktrans(Cp(t)− Ce(t)), (9)
where Ce and Cp are the CA concentrations [mmol/L] inVe and Vp respectively; K
trans [min−1]
is the volume transfer constant between Vp and Ve (see fig. 5) (Tofts, 1997).
There exist a fundamental relationship between Ktrans and ve (Tofts et al., 1999):
83ynamic Co trast E hanced Ma etic Resonance Imaging in Rectal Cancer
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kep = K
trans/ve, (10)
where kep is the rate constant (see fig. 5). The rate constant can be derived from the shape of the
TIC.
The other two parameters in fig. 5 represent the input function from the injection of
gadolinium based contrast (kin) and the clearance rate (kel) (Choyke et al., 2003).
Both blood plasma flow and blood perfusion (capillary permeability) contribute to the value
of Ktrans. If the flow of CA to the tissue is large, Ktrans is dominated by the capillary wall
permeability (permeability surface area, PS); if the delivery of CA to the tissue is insufficient,
blood perfusion will be the dominant factor, and Ktrans will be proportional to the blood flow
F (volume of blood per unit time):
Ktrans = F · E (11)
where E is the extraction fraction of the tracer E = 1 − exp(− PSF ) (PS is the permeability
surface area product).
The relationships described above form the basis of the models used to describe contrast agent
kinetics by a number of researchers, and the conventions for the names and symbols used are
now generally accepted (Tofts et al., 1999).
In normal tissues, the vascular volume is a small fraction vp ≈ 0 of the total tissue volume
VT (approximately 5% , although it can be considerably higher in some tissues), and it is
sometimes assumed (largely as a matter of convenience) that the tracer concentration in the
tissue as a whole, CT, is not influenced to a large degree by the concentration in the vessels
(i.e. CT = vpCp + veCe ≃ veCe).
While this assumption is acceptable in abnormalities with small increase in blood volume,
that are located in tissues with a relatively low normal blood volume, it is not valid in many
contexts, especially because blood volume can largely increase in tumours.
Perhaps the most straightforward approach is to extend eq. 9 to include the concentration of
contrast agent in the blood plasma, giving CT = vpCp + veCe. Using this relationship and eq.
9 we have the extended Tofts’ model (see fig. 6):
CT(t) = vpCp(t) + K
trans
∫ t
0
Cp(τ) exp
(
−
Ktrans
ve
(t− τ)
)
dτ, (12)
More comprehensivemodels, such as the one proposed by St Lawrence & Lee (1998) can allow
direct quantification of flow (F), extraction fraction (E), ve and mean capillary transit time
(MTT). Here, rather than defining a composite parameter Ktrans, it is possible to separately
estimate F and PS (permeability surface area product). As this model has many parameters,
successful application requires a high temporal resolution and an accurate measurement of
CT, which limits its application in clinical trials. The tissue concentration is given by the
following equation (St Lawrence & Lee, 1998):
CT(t) = F
∫ MTT
0
Cp(t− u)du + E · F
∫ t
MTT
Cp(u)e
− E·Fve (t−u−MTT)du (13)
In general, the aim of the compartmental analysis is to estimate the parameters Ktrans,vp
and ve from DCE-MRI data (Leach et al., 2005). This problem can be seen either as a system
identification problem or as a non linear regression problem (Sourbron, 2010). The limited scope
of this chapter does not allow for a deep description of these techniques. We will instead
84 Rectal Cancer – A Multidisciplinary Approach to Management
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discuss in further detail an important issue that is prominent whichever approach is used: the
influence of Cp(t), the arterial input function (AIF).
4.2.1 Influence of the arterial input function
>From eq. (12) it is clear that the CT can be seen as the output of a linear systemwhose impulse
response is determined by the tracer kinetics parameters Ktrans ad ve and whose input is the
AIF. Therefore, errors in estimation of AIF can seriously affect the parameters estimates.
AIF can be obtained by direct measurement of blood flux (Yang et al., 2004). For example,
Larsson et al. (1996) utilised an AIF measured from blood samples drawn from the brachial
artery at intervals of 15 s during the DCE-MRI data acquisition. This method is not suitable
for clinical practice and other approaches have been proposed.
One of the simplest methods was proposed by Brix et al. (1991): they assumed that AIF
followed a mono-exponential model and included it as a third parameter directly into the TIC
model (se fig. 6 (b)). Another approach for modelling of arterial flux was based on population
parameters: the early application proposed by Tofts (1997) assumed a bi-exponential
form of the AIF as previously found in normal population (Weinmann et al., 1984). Also
multi-exponential modelling by means of nonlinear fitting of arterial flux measured directly
on the images on a patient by patient basis has been investigated (Larsson et al., 1996).
Exponential modelling has shown to be only applicable when the sampling rate is relatively
slow and there is a negligible plasma fraction. When the plasma fraction is non-negligible,
this approach tends to over-estimate the volume transfer constant Ktrans. To overcome
this problem, Parker et al. (2006) measured a high temporal resolution population AIF on a
large number of individuals and estimated the parameters of a sophisticated model. Later,
Orton et al. (2008) proposed a computationally efficient version of this model decomposing
the input function into a bolus model and a body transfer function:
Cp(t) = ABte
−µBt + AG(e
−µGt − e−µBt). (14)
A similar model for AIF has been previously proposed by Simpson et al. (1999):
Cp(t) = A · t · e
−t·B + C[1− e−t·D] · e−t·E (15)
where A, B, C, D, E were estimated on an individual basis.
Also, other approaches based on reference tissues have been proposed (Walker-Samuel et al.,
2007; Yankeelov et al., 2005). The development of many analysis methods has proceeded
in tandem with specific data acquisition programmes, and the modelling assumptions
frequently reflected limitations imposed by the data. Care must therefore be taken in applying
these methods in settings other than those originally intended and in comparing apparently
compatible results from different studies using different models and/or data acquisitions.
4.3 ROI vs pixel-by-pixel
Region Of Interest (ROI)-based analysis involves the selection (manual or [semi]-automatic)
of a ROI and subsequently averaging of the TICs over the ROI (fig. 2). The data-analysis is
then applied on the averaged TIC. ROI-based analysis has the advantages of speed and ease of
use; moreover, if the ROI is opportunely chosen the SNR can be increased. However, it has the
disadvantage of intra-observer variability; moreover, ROI-based analysis could be unable to
catch heterogeneity within the tumour (Jackson et al., 2007). Further, inappropriate selection
85ynamic Co trast E hanced Ma etic Resonance Imaging in Rectal Cancer
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Fig. 6. a) The ROIs selected by an expert radiologist on the artery and on the tissue of
interest; b) the time intensity curve of AIF; c) Curve fitting using the Tofts model.
of the ROI, so that it includes both enhancing and necrotic or non-enhancing components of
the tumour, could give misleading interpretation.
These shortcomings can be addressed applying the data-analysis on a pixel-by-pixel basis
obtaining a map for each chosen parameter (Fig. 7). Pixel by pixel analysis deals specifically
with tumour heterogeneity and potentially provides a far wider range of information
concerning tumour behaviour than is available from ROI analysis. Summary values within
a ROI can subsequently be obtained averaging the parametric map. Unfortunately, the use
of parametric images imposes significant further demands on the acquisition and analysis
techniques. In particular, the use of pixel by pixel analysis assumes that there is negligible
motion at the spatial resolution of the individual voxel.
An hybrid approach consists in using parametric maps for ROI selection and subsequent
application of data analysis to the ROI. This approach can potentially benefit from both
ROI-based and pixel-by-pixel processing (Sourbron, 2010).
Also, semi-automatic approaches for model-based segmentation of DCE-MRI images are
currently being developed (Buonaccorsi et al., 2007; Kelm et al., 2009; Sansone et al., 2011;
Schmid et al., 2006; Xiaohua et al., 2005)
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Fig. 7. Example of parametric maps. The pulse sequence had
TE/TR/FlipAngle=4.76ms/9.8ms/25◦ , pixel resolution 0.6 x 0.6 mm x mm, sampling
interval of 34 s. a) T1-weighted image: the rectangle surrounds the ROI chosen by a
radiologist; b) Ktrans map; c) kep map; d) ve map. e) Area under the Gd curve (AUC);
87ynamic Co trast E hanced Ma etic Resonance Imaging in Rectal Cancer
www.intechopen.com
14 Will-be-set-by-IN-T-ECH
5. DCE-MRI in rectal cancer
In this section we will discuss a number of studies reporting findings concerning the
application of DCE-MRI to rectal cancer. Mainly, DCE-MRI has been applied for both cancer
staging and therapy response evaluation. Studies can be grouped according to the approach
used: either semi-quantitative or full-quantitative (see section (4)).
As discussed in section (4), in principle, a full model-based approach should provide
information directly related to vessels permeability and blood flow, thus evidencing
vasculature modification caused by chemo-radiotherapy. However, drawbacks of this
approach include: a great accuracy is required for gadolinium quantification; model choice
is not always clear; parameters estimation is affected by the specific algorithm chosen.
The semi-quantitative approach, instead, although providing summary information, roughly
related to the patophysiology of the cancer, could be more robust in clinical settings.
Blomqvist et al. (1998) proposed a piecewise linear fitting of the TIC. The TIC was divided
into three parts: the first part was characterised by the time needed for the contrast
medium to reach the ROI; the second part was characterised by the rapid increase in signal
intensity (wash-in); the third part presented little or no increase in CA. In their study, none
of the parameters in the piecewise linear approximation were found to significantly help
discriminating malignant from benign. WOI was the only parameter that was significantly
different between the malignant and benign groups.
Preoperative TNM staging of rectal cancer using endorectal coil and dynamic contrast
enhancement, was performed by Drew et al. (1999) using visual inspection based on the
pattern of the enhancement: they found a substantial tumour over-staging when compared to
pathological specimens.
Dicle et al. (1999) evaluated the accuracy of DCE-MRI in the differentiation of malignant and
benign pelvic lesions during follow-up of patients with treated colorectal tumours, using a
semi-quantitative approach. They calculated the maximum change in relative enhancement
Emax (which is related to MSD), the acceleration rate of the TIC (which can be identified
approximately as WIS) and the ratio of the signal intensity of the lesions to the signal intensity
of the iliac artery at 60 s ((SL/SA)60). The acceleration rate of the TIC and (SL/SA)60 were
found to be valuable in the differential diagnosis; Emax showed no capability to differentiate
benign frommalignant lesions. Sensitivity was 83% for each calculated parameter. (SL/SA)60
had the highest specificity and accuracy among the parameters.
de Vries et al. (2000) have monitored 11 patients with cT3 rectal carcinoma who underwent
preoperative chemoirradiation. They looked for a relationship between the PI (eq. 7) with
therapy outcome. They used a short sampling interval of 14s in the wash-in phase (first 10
minutes of acquisition) followed by a longer interval (2min) in the subsequent period (up to 50
min). They found that PI increased after the 1st and 2nd week of treatment. Monitoring of PI
values before therapy seemed to have a prognostic value: they found a significant correlation
between PI before therapy and N downstaging.
After, de Vries et al. (2001) evaluated 17 patients using a similar methodology. Moreover in
this study they evaluated also the tumor heterogeneity. They found similar results.
Later, the same research group de Vries et al. (2003) observed further 34 patients with
primary rectal carcinoma and preoperative chemoirradiation. They found that the PI of
non-responders before therapy was higher than responders. They showed the possible role
of an increased angiogenic activity in aggressive tumour cell clusters that resulted in reduced
nutrient supply and higher fraction of intratumoral necrosis.
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Study Parameters Final Diag. Nr. Pat. Nr. Images
Blomqvist et al. (1998) TTP, WIS, WOI, WOS TNM 30 60
Drew et al. (1999) TNM 29
Dicle et al. (1999) MSD, (SL/SA)60 biopsy 19
de Vries et al. (2000) PI TNM 11 31 + (15)
de Vries et al. (2001) PI TNM 17
de Vries et al. (2003) PI TNM 34 31 + (15)
Kremser et al. (2007) PI TNM 58 15
Tuncbilek et al. (2004) MSD1min,MSD,%/s,TWI MVD 21 8
Zhang et al. (2008) ERpeak,TTP,Tf irst,uptake rate MVD,VEGF 38 15-20
Müller-Schimpfle et al. (1993) Ktrans,ve needle biopsy 18 24
George et al. (2001) Ktrans VEGF 31 42
Torricelli et al. (2003) relative enhanchement biopsy/surgery 36 11-13
de Lussanet et al. (2005) Ktrans, kep,ve,PI MVD,CD31,CD34 17 250
Atkin et al. (2006) Ktrans,ve,MSD MVD,CD31,VEGF 14 40
Ceelen et al. (2006) Ktrans,ve MVD,VEGF,pO2 11 (rats) 500
Mross et al. (2009) Ktrans, AUC VEGF 22 106
Yao et al. (2011) Ktrans,ve , kep MVD,TNM 26 25
Gu et al. (2011) Ktrans,ve , kep TNM 26 10
Table 2. Summary of the main characteristics of the examined DCE-MRI rectal cancer studies. Per each
parameters examined; the method used for final diagnosis; the number of patients; the number of im
between them.
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In line with these results, the same researchers published another paper (Kremser et al., 2007)
in which they examined, using similar methodology, 58 patients before chemo-radiotherapy .
Once again they found that PI is a good predictor of therapy outcome, being, before therapy,
the PI of non-responders lower than responders.
Torricelli et al. (2003) elaborated dynamic images with a semi-quantitative postprocessing
by plotting TICs and calculating the percentage of signal increase at the end of the first
postcontrast dynamic sequence. The pelvic lesionswere classified as recurrent or not recurrent
by applying the following diagnostic criteria: (a) morphology and signal intensity of the
lesion in unenhanced sequences and (b) percentage of enhancement in dynamic enhanced
sequences. Unenhanced MRI had 80% sensitivity and 86% specificity. Analysis of the
percentage of enhancement showed 87% sensitivity and 100% specificity.
Tuncbilek et al. (2004) studied 21 consecutive patients without radiotherapy (RT). They
observed that TTP, WIImax and Emax/1 were strong correlated with microvessel density
(MVD). As regards prognostic value, they found that histologic grade and Emax/1 correctly
predicted metastases in 66.7% and 90.5 % of cases respectively.
Using a 3T scanner and basing on a semi-quantitative approach Zhang et al. (2008) found
that rectal carcinoma had higher ERpeak, higher uptake rate ERpeak/Tpeak, earlier Tpeak, earlier
Tf irstenhanceent, than normal rectal wall.
All the previous studies showed that a semi-quantitative approach is feasible and can have
good performances. In particular the perfusion index (PI) has shown to be a simple and
robust prognostic factor.
On the other side, general guidelines for tracer kinetics approach have been indicated by
Leach et al. (2005). Primary (Ktrans, AUC) and secondary (ve, kep) endpoints have been
recommended.
Tracer kinetics modelling has been applied to the rectal cancer by Müller-Schimpfle et al.
(1993) who reported 91-100 % sensitivity in differentiating benign from malignant lesions
in pelvic lesions. Furthermore, they demonstrated that malignant lesions showed faster
and greater enhancement compared with benign lesions and claimed that a more accurate
differentiation with the usage of dynamic gadolinium-enhanced MRI could be obtained than
with standard contrast-enhanced MRI.
As regards the therapy response, George et al. (2001) showed a correlation between Ktrans and
VEGF tumour expression showing that tumours having higher permeability seemed to better
respond to pre-CRT than tumours having lower permeability.
de Lussanet et al. (2005) evaluated radio-therapy related microvascular changes in locally
advanced rectal cancer (LARC) by DCE-MRI quantitative approach and histology. This
study showed that Ktrans values presents significant radio-therapy related reductions in
microvessel blood flow in locally advanced rectal cancer. They studied tumor heterogeneity
using histograms of Ktrans, ve and evaluatingmedina tumor values andmedian tumor/muscle
ratio. Radiation therapy damages all blood vessels, but specific effects depend on vessel size,
location, and dose-time-volume factors. Although acute effects of RT are marked by increased
microvascular permeability, related to endothelial cell damage and local inflammation, longer
term effects are marked by decreased permeability, resulting from basement membrane
thickening and extracapillary fibrosis. The DCE-MRI volume fraction EES (ve) showed some
increased variation after Rt. Cell destruction caused by radiation may have increased the
relative EES to which the CA can leak. In other part of the tumor infiltration of inflammatory
cells can decrease EES.
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(a) (b)
(c) (d)
Fig. 8. (a) A heterogeneous irregular thickening along the entire rectal wall is well shown on
T2w axial pre-pCRT scan (arrowheads). (b) After pCRT, a hypo-intense spiculated area with
thin digitations into peri-rectal fat is visible on T2w axial scan (arrowheads). (c) In the same
patient, multiple irregular rectal wall thickening are shown on T2w sagittal pre-pCRT scan
(arrowheads). (d) A single hypo-intense area, showed also in (b) is pointed by arrowheads,
suspecting for a residual post-pCRT tumor focus (arrowheads).
Controversially, Atkin et al. (2006) analysed 14, by preoperative DCE-MRI, patients that
had not undergone any previous chemo-radioherapy. They reported a negative correlation
between transfer constant Ktrans with CD31. They noticed that this correlation is paradoxical
because Ktrans should be posiively coupled to blood flow,microvessel permeability and surface
area. They suggested that this paradox could be related to the high level of maturation of
vessels within rectal cancers, with mature vessels demonstrating relatively low permeability.
Moreover, they reported no correlation of DCE-MRIwith other measures such as MVD (which
provide anatomical data only). Therefore they concluded that DCE-MRI does not simply
reflect static histological vascular properties in patients with rectal cancer.
Monitoring 11 rats before and after fractionated short-term radiotherapy (Ceelen et al., 2006)
observed a significant reduction of Ktrans and ve, while in non irradiated muscle tissue no
changes were observed. After RT, pO2 levels were inversely related to both K
trans and ve. No
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Fig. 9. T1w post-contrast scan obtained on the same patient in fig. 8, before (a)-(b) and after
(c)-(d) pre-CRT. The analysis of TIC calculated on a ROI, drawn outside the rectal wall where
on T2w scans (fig. 8) tumor clearly spreads into peri-rectal fat pad, confirm this suspect
showing a rapid CA intake and a fast discharge (b). After pre-CRT, on the same areas
showed on T2w scans (fig. 8) no pathological CA uptake is present confirming that
hypo-intense tissue visible on T2w scans are tumor nests but only residual inflammation due
to pre-CRT. This patient was considered as a Responder. Histopathology showed a TRG 1.
correlationwas found between DCE-MRI parameters and histologic parameters (MVD, VEGF
expression). MVD did not differ significantly between RT-trated and control animals.
Mross et al. (2009) proposed an hybrid approach including AUC and Ktrans for evaluating the
response to treatment of 22 patients.
Yao et al. (2011) reported moderate and strong relationship between Ktrans and
clinicopathological elements, Ktrans might be the prognostic indicator of rectal cancer.
Gu et al. (2011) found a positive correlations between kep and SUV values in primary rectal
adenocarcinomas suggesting an association between angiogenesis and metabolic activity and
further reflecting that angiogenic activity in washout phase is better associated with tumor
metabolism than the uptake phase.
Although these encouraging results, the evaluation after neo-adjuvant therapy remains
actually difficult in borderline cases where an overestimation is the most common drawback.
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This phenomenon has been addressed to the presence of inflammatory tissue still mostly
vascularized so as tumour residual areas (see fig. 8 and 9).
In conclusion, DCE-MRI can be considered a valuable tool for clinical investigation of rectal
cancer, in particular for re-staging and therapy evaluation. Further improvements should
involve the underestimation phenomenon, a clinically relevant problem, frequently observed
on morphologic MRI that is not yet been solved because of the presence of small areas of
tumors within poorly vascularized fibrotic tissue under the spatial resolution of DCE-MRI
technique.
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